SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001601485-22-000037
Filing Date
2022-05-16
Accepted
2022-05-16 16:14:56
Documents
74
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q angn-20220331.htm   iXBRL 10-Q 1415072
2 EX-31.1 ex311_angnx03312022-10xq.htm EX-31.1 10574
3 EX-31.2 ex312_angnx03312022-10xq.htm EX-31.2 10020
4 EX-32.1 ex321angn-03312022x10xq.htm EX-32.1 6117
5 EX-32.2 ex322_angnx03312022-10xq.htm EX-32.2 6178
  Complete submission text file 0001601485-22-000037.txt   6705497

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20220331.xsd EX-101.SCH 46228
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT angn-20220331_cal.xml EX-101.CAL 70572
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT angn-20220331_def.xml EX-101.DEF 266535
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20220331_lab.xml EX-101.LAB 632250
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20220331_pre.xml EX-101.PRE 412056
68 EXTRACTED XBRL INSTANCE DOCUMENT angn-20220331_htm.xml XML 930899
Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39990 | Film No.: 22929194
SIC: 2834 Pharmaceutical Preparations